StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Reaktion

2-Dimethylaminopyridine → HCID 178499660, Verbindung

HRID 460735
Drucken

Reaktionsgleichung

Reaktionsgleichung von HRID 460735
[CH:1]1([C:7]2[C:12](=[O:13])[N:11]3[N:14]=[C:15]([C:17](O)=[O:18])[CH:16]=[C:10]3[NH:9][C:8]=2[C:20]2[O:21][CH:22]=[CH:23][CH:24]=2)[CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]1.[CH:25]([N:28]([CH:31]([CH3:33])[CH3:32])CC)([CH3:27])[CH3:26].CN([C:37]1[CH:42]=[CH:41]C=CN=1)C.Cl.[CH3:44][O:45][C:46](=[O:59])[C@H:47](CC1C2C(=CC=CC=2)NC=1)[NH2:48].CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F>CN(C)C=O.C(OCC)(=O)C>[CH3:44][O:45][C:46](=[O:59])[CH:47]([NH:48][C:17]([C:15]1[CH:16]=[C:10]2[NH:9][C:8]([C:20]3[O:21][CH:22]=[CH:23][CH:24]=3)=[C:7]([CH:1]3[CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]3)[C:12](=[O:13])[N:11]2[N:14]=1)=[O:18])[CH2:33][C:31]1[NH:28][C:25]2[C:26]([CH:32]=1)=[CH:41][CH:42]=[CH:37][CH:27]=2
KomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

8

Edukt 5

HCID 218852-DimethylaminopyridineHCID 81531DiisopropylethylamineHCID 2734891Methyl tryptophanate hydrochlorideHCID 9886157Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 178524066HCID 178524066, Verbindung

Produkt 1

HCID 178499660
HCID 178499660, Verbindung
Ausbeute 39 %

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 6228DimethylformamideLösungsmittelHCID 8857Ethyl AcetateLösungsmittel

Versuchsvorschrift

To a solution of 8.2 mg (0.025 mmol) of 6-cyclohexyl-5-furan-2-yl-7-oxo-4,7-dihydro-pyrazolo[1,5-a]pyrimidine-2-carboxylic acid in 2 mL of dimethylformamide (DMF) was added 0.009 mL (0.05 mmol) of diisopropylethylamine (DIEA), a few crystals of dimethylaminopyridine (DMAP cat), 7 mg (0.027 mmol) of L-tryptophan methyl ester hydrochloride, followed by 11 mg (0.03 mmol) of HATU, and the resulting mixture was stirred at rt overnight. The reaction mixture was diluted with ethyl acetate, washed with 0.1 N sodium hydroxide solution (2 times) and brine. The separated organic layer was dried over sodium sulfate and concentrated to give a residue which was purified via reverse-phase chromatography (Gilson) to afford desired 2-[(6-cyclohexyl-5-furan-2-yl-7-oxo-4,7-dihydro-pyrazolo[1,5-a]pyrimidine-2-carbonyl)-amino]-3-(1H-indol-2-yl)-propionic acid methyl ester (606). This compound was then converted to 2-[(6-cyclohexyl-5-furan-2-yl-7-oxo-4,7-dihydro-pyrazolo[1,5-a]pyrimidine-2-carbonyl)-amino]-3-(1H-indol-2-yl)-propionic acid (599) via the well known LiOH saponification protocol (39% yield over 2 steps); LC-MS calcd. for C28H27N5O5 [M++H]+: 514.2; found: 514.2.

Aufarbeitung

  1. washwashed with 0.1 N sodium hydroxide solution (2 times) and brine
  2. dry with materialThe separated organic layer was dried over sodium sulfate
  3. concentrationconcentrated
  4. customto give a residue which
  5. customwas purified via reverse-phase chromatography (Gilson)

Quellen und Nachweise

ORD-Eintrag
ord-84e2886be21f4bc6a03ad4e1e9519913
Quelldatensatz
uspto-grants-2007_03
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US07196111B2

Notizen zur Reaktion

Auf dieser SeiteKomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion